Jeffrey R. Stewart
Executive Vice President, Chief Commercial Officer
AbbVie Inc. · ABBV
$15.4M
Reported total · FY2025 · SCT Total as filed
Source: DEF 14A filed March 23, 2026. Prior years are from that filing's three-year table.
Catalog as of September 15, 2026. Not a live market feed.
- Salary
- $1.3M
- Stock Awards
- $5.4M
- Option Awards
- $1.3M
- Incentives
- $3M
- Other
- $4.5M
Compensation History
| Fiscal Year | Salary | Stock Awards | Total Compensation |
|---|---|---|---|
| 2025 | $1,315,726 | $5,390,310 | $15,435,304 |
| 2024 | $1,277,404 | $5,165,930 | $14,047,300 |
| 2023 | $1,188,500 | $4,190,943 | $15,349,558 |
Current Position
- Company
- AbbVie Inc.
- Title
- Executive Vice President, Chief Commercial Officer
- Ticker
- ABBV · NYSE
- Fiscal Year
- 2025
SEC Sources
Fiscal years below are columns from the latest DEF 14A Summary Compensation Table (filed March 23, 2026), not separate historical filings.
| Fiscal Year | Source |
|---|---|
| 2025 | View SEC filing |
| 2024 | View SEC filing |
| 2023 | View SEC filing |
Accession 0001104659-26-033387.
Other AbbVie Executives
Robert A. Michael
Chairman Of The Board And Chief Executive Officer
AbbVie · ABBV
$32.5M
FY 2025 · DEF 14A
Scott T. Reents
Executive Vice President, Chief Financial Officer
AbbVie · ABBV
$12.4M
FY 2025 · DEF 14A
Azita Saleki-Gerhardt
Executive Vice President, Chief Operations Officer
AbbVie · ABBV
$10.8M
FY 2025 · DEF 14A
Roopal B. Thakkar
Executive Vice President, Chief Scientific Officer
AbbVie · ABBV
$9.9M
FY 2025 · DEF 14A